These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 101411)

  • 21. Effect of BCG cell-wall skeleton on metastasis of syngeneic tumor in rats, with special reference to lymphocyte trapping.
    Ogura T; Namba M; Hirao F; Yamawaki M; Azuma I; Yamamura Y
    Gan; 1978 Jun; 69(3):311-5. PubMed ID: 352783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal thymectomy and tumor induction with methylcholanthrene in mice.
    Balner H; Dersjant H
    J Natl Cancer Inst; 1966 Mar; 36(3):513-21. PubMed ID: 18630325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental lung cancer induced by chemical carcinogens and immunity].
    Hirao F; Yoshimoto T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jan; 23(1):46-50. PubMed ID: 3925208
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental cancerous changes in the lung induced by chemical carcinogens in rabbits.
    Hirao F; Fujisawa T; Tsubura E; Akamatsu Y; Yamamura Y
    Gan; 1967 Oct; 58(5):427-34. PubMed ID: 6082818
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant and antitumor activities of Nocardia cell-wall skeletons.
    Azuma I; Taniyama T; Yamawaki M; Sugimura K; Yamamura Y
    Gan; 1976 Oct; 67(5):733-6. PubMed ID: 797626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined treatment of syngeneic murine tumors and xenotransplanted human lung cancer by immunotherapy and radiotherapy.
    Terashima H; Yasumoto K; Yanagawa E; Takayama K; Nomoto K; Azuma I; Yamamura Y
    Gan; 1981 Jun; 72(3):363-9. PubMed ID: 7033032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets.
    Bartlett GL; Zbar B
    J Natl Cancer Inst; 1973 May; 50(5):1385-90. PubMed ID: 4351399
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of systemic administration of BCG cell walls on bronchogenic carcinoma in hamsters.
    Zwilling BS; Springer ST; Kaufman DG
    J Natl Cancer Inst; 1977 May; 58(5):1473-7. PubMed ID: 323508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plaque-forming cells in the spleens of rabbits immunized with viable BCG bacilli or oil cell wall vaccine from Mycobacterium bovis.
    Larson C; Baker MB; Smith D
    Am Rev Respir Dis; 1968 Apr; 97(4):715-8. PubMed ID: 4868647
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental lung cancer in rabbits induced by chemical carcinogens.
    Hirao F; Fujisawa T; Tsubura E; Akamatsu Y; Yamamura Y
    Gan; 1968 Dec; 59(6):497-505. PubMed ID: 5721582
    [No Abstract]   [Full Text] [Related]  

  • 31. [Action mechanism of cell wall skeleton of BCG and Nocardia rubra as immunomodulator].
    Ogura T; Yoshimoto T; Sakatani M; Nishikawa H; Masuno T; Kawase I; Namba M; Hirao F; Yamamura Y; Itoh M
    Nihon Rinsho; 1981 Apr; 39(4):1852-60. PubMed ID: 7031297
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
    Yamamura Y; Sakatani M; Ogura T; Azuma I
    Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on antitumor effect of cell-wall skeleton of Mycobacterium bovis BCG and Nocardia rubra, with reference to T-cell dependency and independency.
    Yanagawa E; Yasumoto K; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Gan; 1979 Apr; 70(2):141-6. PubMed ID: 381087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE; Meyer TJ; Azuma I; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
    Nishikawa H; Yasaki S; Yoshimoto T; Sakatani M; Itoh M; Masuno T; Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
    Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
    Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
    [No Abstract]   [Full Text] [Related]  

  • 37. Antitumor activity of cell-wall skeletons and peptidoglycolipids of mycobacteria and related microörganisms in mice and rabbits.
    Azuma I; Taniyama T; Hirao F; Yamamura Y
    Gan; 1974 Dec; 65(6):493-505. PubMed ID: 4219357
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
    Morishita M
    Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of oil-attached BCG cell wall on the kinetics of lymphocytes in the tumor-draining node.
    Ogura T; Azuma I; Nishikawa H; Namba M; Hirao F
    Gan; 1975 Aug; 66(4):349-54. PubMed ID: 171193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunologic capacity of cancer patients and BCG-CSW immunotherapy].
    Yasumoto K; Manabe H; Yanagawa E; Nagano S; Ueda H
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):449-51. PubMed ID: 381535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.